FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/02/017857 [Registered on: 27/02/2019] Trial Registered Prospectively
Last Modified On: 12/05/2020
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study
Modification(s)  
Unani 
Study Design  Single Arm Study 
Public Title of Study   Treatment of Dermatophytosis (Ringworm) with Unani medicine Majoon-e-Ushba and Marham Qooba 
Scientific Title of Study   Clinical Validation of Unani Pharmacopoeial formulations Majoon-e- Ushba and Marham Qooba in Qooba (Dermatophytosis) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
Q/D/MU/MQ/CLNVAL/CCRUM /17-18, version 1  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Asim Ali Khan 
Designation  Director General 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  01128525715  
Fax    
Email  unanimedicine@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naheed Parveen 
Designation  Assistant Director 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  9213511298  
Fax    
Email  ccrum507@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pradeep Kumar 
Designation  Research Officer (Pathology) S-IV 
Affiliation  Central Council for Research in Unani Medicine (CCRUM) 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri

South West
DELHI
110058
India 
Phone  8800263300  
Fax    
Email  drpradeepkumar2001@yahoo.com  
 
Source of Monetary or Material Support  
Infrastructural support : 1 Regional Research Institute of Unani Medicine (RRIUM), Mumbai 2. Regional Research Institute of Unani Medicine (RRIUM), Chennai 3. Regional Research Institute of Unani Medicine (RRIUM), Patna Monetary Support : Central Council for Research in Unani Medicine (CCRUM), New Delhi 
 
Primary Sponsor  
Name  Central Council for Research in Unani Medicine CCRUM 
Address  Jawahar Lal Nehru Bhartiya Chikitsa Evam Homoeopathy Anusandhan Bhawan, 61-65, Institutional Area, Opp. D Block, Janakpuri, New Delhi-110058. 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
Nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 3  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Irfan Ahmad  Regional Research Institute of Unani Medicine (RRIUM)  Behind Eye Bank, Sir J J Hospital Compound, Byculla Research OPD Room (Qooba)
Mumbai
MAHARASHTRA 
02223742173

rrium.mumbai@gmail.com 
Dr K Kabiruddin Ahmed  Regional Research Institute of Unani Medicine (RRIUM)  1, West Madha Church, Royapuram Research OPD Room (Qooba)
Chennai
TAMIL NADU 
9444219145

drk.kabiruddin@rediffmail.com 
Dr Mohd Manzar Alam  Regional Research Institute of Unani Medicine (RRIUM)  Guzri, Patna City Research OPD Room (Qooba)
Patna
BIHAR 
7488966960

manzar.medicine@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 3  
Name of Committee  Approval Status 
Regional Research Institute of Unani Medicine, Chennai  Approved 
Regional Research Institute of Unani Medicine, Mumbai  Approved 
Regional Research Institute of Unani Medicine, Patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: B359||Dermatophytosis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Majoon-e- Ushba and Marham Qooba  Majoon-e- Ushba 10 g Twice daily Orally with water for 5 weeks Marham Qooba Q.S. Twice daily Topically on the affected area after rubbing for few seconds for 5 weeks. 
Comparator Agent  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Patients of either sex aged between 18- 65 years
2. Subjects with KOH positive/microscopically confirmed
3. Clinical signs and symptoms suggestive of fungal infection viz. annular / arcuate
polycyclic lesion with clear centre and an active margin with papulo-vesicles & scaling;
erythema, itching, burning. 
 
ExclusionCriteria 
Details  1. Patients of either sex < 18 years and > 65 years
2. Superficial skin disease like Eczema/psoriasis/scabies
3. Superadded infections
4. Lactating and pregnant women
5. Subjects with Tinea capitis (tinea of scalp), Onychomycosis (tinea of nails) and Tinea
barbae (tinea of beard)
6. Subjects who are concomitantly using any anti-fungal product in any form
7. Known cases of allergy to any ingredients of the study drug
8. Subjects with systemic diseases requiring long-term treatment
9. Subjects not willing to undergo the specified washout periods (for topical preparations
not less than 2 weeks & for systemic medicines 4 weeks) 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in sign and symptoms of Qooba (Dermatophytosis)  05 weeks.  
 
Secondary Outcome  
Outcome  TimePoints 
Haematological and biochemical assessment for safety assessment  Investigations will be done at baseline and end of treatment  
 
Target Sample Size   Total Sample Size="240"
Sample Size from India="240" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   28/02/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   not yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This study is designed as a multicentric open trial in patients with Qooba (Dermatophytosis)After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at week 0, 02 and 05This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 5 weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

Composition of Majoon-e-Ushba

 

S. No.

Unani Name

Scientific Name

Weight

1.                             

Ushba

Smilax ornate Lem.

20 g

2.                             

Bisfaij Fastaqi

Polypodium vulgare Linn.

20 g

3.                             

Aftimun Vilayti

Cuscuta eurea Linn.

20 g

4.                             

Barg-e-Gawzaban

Onasma bracteatum Wall.

20 g

5.                             

Kabab chini

Piper cuceba Linn.

20 g

6.                             

Darchini

Cinnamonium zeylanicum

20 g

7.                             

Gule Surkh

Rosa damascene

30 g

8.                             

Chobchini

Smilax china Linn.

30 g

9.                             

Sandal Safaid

Santalum album Linn.

30 g

10.                         

Sandal Surkh

Pterocarpus santalinus Linn.

30 g

11.                         

Senna Makki

Cassia angustifolia

40 g

12.                         

Post Balela,

Terminalia belirica Roxb.

10 g

13.                         

Sumbul-ut-Teeb

Valeriana jatamansi DC.

10 g

14.                         

Halela Siyah

Terminalia chebula Retz.(Black)

7 g

15.                         

Post Halela Zard

Terminalia chebula Retz.(yellow)

6 g

16.                         

Qand Safaid

Sucrose

750 g

17.                         

Shahad

Honey

500 g

 
Close